In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation

被引:31
|
作者
Owens, Christopher D. [1 ]
Wake, Nicole [2 ]
Conte, Michael S. [1 ]
Gerhard-Herman, Marie [2 ]
Beckman, Joshua A. [2 ]
机构
[1] Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94143 USA
[2] Brigham & Womens Hosp, Dept Cardiol, Div Cardiovasc Med, Boston, MA 02115 USA
关键词
NITRIC-OXIDE SYNTHASE; ENDOTHELIUM-DEPENDENT RESPONSES; CORONARY-ARTERY DISEASE; CANINE ARTERIAL; BRACHIAL-ARTERY; WALL STIFFNESS; SMOOTH-MUSCLE; RELAXATION; ACETYLCHOLINE; CIRCULATION;
D O I
10.1016/j.jvs.2009.06.022
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: As in arteries, venous endothelium modulates vessel homeostasis and tone. The effect of an arterialized environment on venous endothelial function remains poorly understood. In particular, regulation of saphenous vein graft (SVG) blood flow and lumen caliber remains undefined. We hypothesized that mature SVGs would exhibit endothelium-dependent, flow-mediated vasodilation (FMD). We further hypothesized that endothelium-derived nitric oxide (NO) was an important mediator. Methods. Patients with femoral to popliteal artery SVGs that had maintained primary patency and were at least 1 year from surgery were enrolled. High-resolution, B-mode ultrasound scans were used to measure vein graft diameter before and I minute after reactive hyperemia (RH) to determine FMD. RH was created through application of 220 mm Hg to the calf for 5 minutes with a sphygmomanometric cuff. After a 10-minute recovery period, nitroglycerin-mediated, endothelium-independent vasodilation was measured 3 minutes after administration of nitroglycerin 0.4 mg sublingually. Brachial artery FMD was determined by validated techniques. L-N(G)monomethyl arginine (L-NMMA; 1 mg/kg infusion over 10 minutes) was used in a subset of patients (n = 6) to competitively inhibit endothelial NO synthase. Results. Nineteen subjects were enrolled. The median age of the SVGs was 34.6 (21.0-49.7) months. SVG flow-mediated, endothelium-dependent vasodilation was measured at 5.28% +/- 3.1% mean change in lumen diameter (range, 1.99%-9.36%; P < .0001 for diameter change). Nitroglycerin-mediated vasodilation was 3.7% +/- 1.0%, (range, 16%-10.04%; P < .005). Intravenous administration of L-NMMA abolished SVG FMD (5.7 +/- 1.4% before L-NMMA vs 0.01 +/- 0.01% during L-NMMA infusion; P = .0088) and attenuated brachial artery FMD (7.54% +/- 1.0% vs 5.7 +/- 1.4; P = .05). Conclusion: SVGs manifest flow-mediated, endothelium-dependent, and nitroglycerin-mediated endothelium-independent vasodilation. Vein graft endothelium-dependent FMD is likely mediated by NO. Further investigation will be required to determine the role of endothelial function in vein graft patency. (J Vasc Surg 2009;50:1063-70.)
引用
收藏
页码:1063 / 1070
页数:8
相关论文
共 50 条
  • [1] In vivo human lower-extremity saphenous vein bypass grafts manifest flow-mediated vasodilation
    Owens, Christopher D.
    Wake, Nicole
    Conte, Michael S.
    Schanzer, Andres
    Gerhard-Herman, Marie D.
    Creager, Mark A.
    Beckman, Joshua A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E133 - E133
  • [2] The Management of Aneurysmal Degeneration of Lower Extremity Cryopreserved Saphenous Vein Bypass Grafts
    Li, Richard
    Cammarata, Tessabella Michelina Magliochetti
    Gasienica, Jacob
    Gould, Anders
    Linjawi, Hamad
    Wheatley, Brian
    ANNALS OF VASCULAR SURGERY, 2024, 105 : 82 - 88
  • [3] Small Saphenous Vein and Arm Vein as Bypass Grafts for Upper Extremity Ischemia
    Nierlich, Patrick
    Enzmann, Florian K.
    Dabernig, Werner
    San Martin, Julio Ellacuriaga
    Akhavan, Fatema
    Linni, Klaus
    Hoelzenbein, Thomas
    ANNALS OF VASCULAR SURGERY, 2019, 60 : 264 - 269
  • [4] Flow-mediated dilation in lower-extremity vein grafts
    Smith, BM
    Ellahham, S
    Stanford, JL
    Kohlman-Trigobof, D
    Tupas-Habib, MT
    Molina, H
    VASCULAR SURGERY, 1999, 33 (06): : 595 - 602
  • [5] Outcomes of Endoscopically Harvested Saphenous Vein for Lower Extremity Bypass
    Malgor, R. D.
    Margolis, J. S.
    Montecalvo, J.
    Shahidul, I.
    Hines, G. L.
    ACTA CHIRURGICA BELGICA, 2014, 114 (05) : 319 - 323
  • [6] Human saphenous vein allograft bypass grafts: Immune response
    Carpenter, JP
    Tomaszewski, JE
    JOURNAL OF VASCULAR SURGERY, 1998, 27 (03) : 492 - 499
  • [7] Arm Vein versus Small Saphenous Vein for Lower Extremity Bypass in the Absence of Both Great Saphenous Veins
    Nierlich, Patrick
    Enzmann, Florian K.
    Metzger, Peter
    Dabernig, Werner
    Akhavan, Fatema
    San Martin, Julio Ellacuriaga
    Hitzl, Wolfgang
    Hoelzenbein, Thomas
    ANNALS OF VASCULAR SURGERY, 2021, 70 : 341 - 348
  • [8] LOWER-EXTREMITY INSITU SAPHENOUS-VEIN GRAFTS - ANGIOGRAPHIC INTERVENTIONS
    SNIDERMAN, KW
    KALMAN, PG
    SHEWCHUN, J
    GOLDBERG, REA
    RADIOLOGY, 1989, 170 (03) : 1023 - 1027
  • [9] MYOCARDIAL PERFUSION AND CORONARY FLOW RESERVE IN MAMMARY ARTERY AND SAPHENOUS-VEIN BYPASS GRAFTS WITH MAXIMAL DIPYRIDAMOLE VASODILATION
    LASSAR, T
    HENDRIX, L
    PORT, S
    RAY, G
    KAMATH, ML
    SCHMIDT, DH
    JOURNAL OF NUCLEAR MEDICINE, 1985, 26 (05) : P84 - P84
  • [10] MYOCARDIAL PERFUSION AND CORONARY FLOW RESERVE IN MAMMARY ARTERY AND SAPHENOUS-VEIN BYPASS GRAFTS WITH MAXIMAL DIPYRIDAMOLE VASODILATION
    LASSAR, T
    PORT, S
    RAY, G
    HENDRIX, L
    SCHMIDT, DH
    CLINICAL RESEARCH, 1985, 33 (04): : A810 - A810